tris(2-carboxyethyl)phosphine has been researched along with triiodothyronine in 1 studies
Studies (tris(2-carboxyethyl)phosphine) | Trials (tris(2-carboxyethyl)phosphine) | Recent Studies (post-2010) (tris(2-carboxyethyl)phosphine) | Studies (triiodothyronine) | Trials (triiodothyronine) | Recent Studies (post-2010) (triiodothyronine) |
---|---|---|---|---|---|
266 | 1 | 145 | 26,247 | 861 | 3,473 |
Protein | Taxonomy | tris(2-carboxyethyl)phosphine (IC50) | triiodothyronine (IC50) |
---|---|---|---|
Thyroid hormone receptor alpha | Homo sapiens (human) | 0.0006 | |
Thyroid hormone receptor beta | Homo sapiens (human) | 0.0006 | |
Proliferating cell nuclear antigen | Homo sapiens (human) | 3.6 | |
Thyroid hormone receptor beta | Rattus norvegicus (Norway rat) | 0.0031 | |
Adenosine receptor A1 | Homo sapiens (human) | 0.4109 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Guan, X; Jiang, G; Li, A; Li, Y; Liu, M; Meng, L; Zhang, G; Zhang, Q; Zhu, J | 1 |
1 other study(ies) available for tris(2-carboxyethyl)phosphine and triiodothyronine
Article | Year |
---|---|
Exposure to Novel Brominated Flame Retardants and Organophosphate Esters and Associations with Thyroid Cancer Risk: A Case-Control Study in Eastern China.
Topics: Case-Control Studies; China; Environmental Monitoring; Esters; Female; Flame Retardants; Humans; Male; Organophosphates; Phosphates; Thyroid Neoplasms; Thyroxine; Triiodothyronine | 2022 |